Review of Pseudobulbar Affect Including a Novel and Potential ...

Pseudobulbar affect prevalence in Turkish multiple sclerosis patients

... PBA co- occurrence with depression, and its potential consequences. ... Review of pseudobulbar affect including a novel and potential therapy.

Pseudobulbar Affect (PBA): Causes, Symptoms & Treatment

Some people consider PBA a psychiatric disorder (mental illness) since the observable emotional changes (laughing or crying) are associated with mood. However, ...

Current concepts in the pharmacotherapy of pseudobulbar affect

The syndrome has been described by a plethora of names, including pathological laughing and crying, emotional lability, emotionalism and emotional incontinence, ...

Combined Dextromethorphan and Quinidine in Patients With ...

Pseudobulbar affect is a clinical diagnosis, which might partly explain why the drug was used in a broader population after approval than in the ...

Pseudobulbar Affect - MalaCards

It is typically associated with a neurologic disorder or brain injury. Patients may experience episodes of crying or laughing that are disproportionate to the ...

Pseudobulbar Affect: Burden of Illness in the USA - CORE

PBA pseudobulbar affect, SF-36 36-item short form health survey ... Review of pseudobulbar affect including a novel and potential therapy.

Pseudobulbar Affect (PBA) & Depression | NUEDEXTA®|HCP

Patients with traumatic brain injury may experience anxiety or post-traumatic stress disorder, and patients with dementia may experience aggression, delusions, ...

Pseudobulbar Affect - touchNEUROLOGY

The findings indicate that PBA symptoms are common when specifically sought with a structured instrument, it has a potentially detrimental effect on QoL.

International Journal of Geriatric Psychiatry | Wiley Online Library

Pseudobulbar affect (PBA) is a neurological disorder of emotional expression, characterized by uncontrollable episodes of crying or laughing in ...

Distinguishing pseudobulbar affect from depression: Clinical ...

While not well known, PBA is a secondary condition that manifests as sudden, frequent, uncontrollable episodes of crying and/or laughing, which are ...

Pseudobulbar Affect (PBA) - American Stroke Association

Stroke; Amyotrophic lateral sclerosis (ALS); Parkinson's; Traumatic brain injury; Multiple sclerosis; Dementia. Those with PBA have involuntary ...

Review of Dextromethorphan 20 mg/Quinidine 10 mg (NUEDEXTA ...

Pseudobulbar affect (PBA) is a dysfunction of emotional expression characterized by involuntary outbursts of crying or laughing disproportionate or ...

Reliability, validity and validation of the CNS emotional lability scale ...

components analysis with varimax rotation and three factors ... Pseudobulbar affect including a novel and potential therapy. [review] ...

Post-Stroke Pseudobulbar Affect—Do We Know Enough?

Introduction: Pseudobulbar affect (PBA) is characterized by uncontrolled crying and/or laughing which may be disproportionate or inappropriate to the social ...

Validation of the CNS emotional lability scale for pseudobulbar ...

Pseudobulbar affect (PBA) or pathological laughing and crying (PLC) is a disorder of affect that occurs in about 10% of multiple sclerosis (MS) patients.

PRISM Registry: A Novel Tool To Estimate the Prevalence of ...

BACKGROUND: PBA is a neurological disorder of emotional expression, occurring secondary to a variety of neurological conditions and characterized by ...

Pseudobulbar affect prevalence in Turkish multiple sclerosis patients

1. Schiffer R.; Pope, LE. Review of pseudobulbar affect including a novel and potential therapy. The Journal of neuropsychiatry and clinical ...

pseudobulbar affect pba: Topics by Science.gov

Pseudobulbar Affect - Psychology Today

with possible traumatic brain injury. Journal of Rehabilitation Research and ... bulbar affect after stroke: A narrative review. Topics in Stroke ...

Effects of Dextromethorphan/Quinidine on Auditory Event-Related ...

Schiffer, Pseudobulbar affect including a novel and potential therapy. Review., J Neuropsychiatry Clin Neurosci, № 17, с. 447 https://doi.org/10.1176/jnp ...